The aim of this study is to assess the effects of growth hormone on echocardiographic findings in 32 patients with heart failure, 4 weeks after myocardial infarction (MI). These patients after going through different stages and checking out inclusion criteria, will be divided into two groups of 16. One group for three months, every other day, and each patient will receive 5.0 mg of growth hormone and the second group received placebo in the same way. Echocardiography was undertaken three months later and was repeated again after three month. Then collected data will be analyzed by SPSS software.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201704083035N1
Registration date:2017-07-05, 1396/04/14
Registration timing:retrospective
Last update:
Update count:0
Registration date
2017-07-05, 1396/04/14
Registrant information
Name
Masoumeh Sadeghi
Name of organization / entity
Cardiovascular Research Institute, Isfahan University of MEdical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 31 3611 5208
Email address
m_sadeghi@crc.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Governmental
Expected recruitment start date
2017-01-20, 1395/11/01
Expected recruitment end date
2017-04-21, 1396/02/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)
Public title
The effects of growth hormone (GH) on the results of echocardiography in patients with heart failure (HF) four weeks after myocardial infarction (MI)
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria: Male; first-time MI; Ejection Fraction (EF) < 45% at discharge.
Exclusion criteria: Patients with insulin-dependent diabetes mellitus (IDDM); Failure to control blood pressure (BP) in patients within 4 weeks after discharge from hospital; History of pulmonary disease other than asthma; Known chronic hepatic disease; Cr≥2.5 or GFR≤60; Systemic disease of all types; History of active infection or intake of antibiotics after discharge from hospital; HIV positive; Intake of corticosteroids within the last 4 weeks; Regularly intake of alcohol within 4 weeks after discharge.
11. Any history or evidence from examination for malignant condition
12. Any history indicating malignant condition in patient or his/her first degree relatives
13. Any blood problems (even iron deficiency or anemia)
14. Any skeletal (bone) problems (except osteoporosis)
15. any history of peripheral vascular disease (PVD)
16. Any evidence of severe (Aortic) Valve Stenosis or heart valve failure
17. Any severe valve failure
18. Moderate and severe ventricular hypertrophy
19. Any type of heart block
20. Retinopathy for any reason
21. Any type of thyroid disorder
Age
From 40 years old to 70 years old
Gender
Male
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
32
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features
Secondary Ids
1
Registry name
-
Secondary trial Id
-
Registration date
empty
2
Registry name
-
Secondary trial Id
-
Registration date
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethics committee of Isfahan University of Medical Sciences
Street address
Isfahan University of Medical Sciences, Hezarjereb Ave, Isfahan, Iran
City
Isfahan
Postal code
Approval date
2016-09-22, 1395/07/01
Ethics committee reference number
IR.MUI.REC.1395.8.74
Health conditions studied
1
Description of health condition studied
Heart failure
ICD-10 code
I20-I25
ICD-10 code description
I24.8
Primary outcomes
1
Description
Ejection Fraction (EF)
Timepoint
Immediately after injection, and three months later
Method of measurement
3-Dimentional Echocardiography
2
Description
Ventricular septum and left ventricular wall thickness
Timepoint
Immediately after injection, and three months later
Method of measurement
2-Dimentional Echocardiography
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group 1: Receiving growth hormone a dose of 5 mg, every other day for 3 months through subcutaneous injection
Category
Treatment - Drugs
2
Description
Control group : Receiving placebo
Category
Placebo
Recruitment centers
1
Recruitment center
Name of recruitment center
Shahid Chamran Heart hospital
Full name of responsible person
Masoumeh Sadeghi MD
Street address
Moshtagh sevom Ave, Shahid Chamran Heart hospital
City
Isfahan
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences
Full name of responsible person
Behzad Yavari MD
Street address
Isfahan
City
Isfahan
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, School of Medicine, Isfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty
Person responsible for general inquiries
Contact
Name of organization / entity
Isfahan Cardiovascular Research Institute
Full name of responsible person
Masoumeh Sadeghi MD
Position
Professor of Cardiology
Other areas of specialty/work
Street address
Cardiovascular Research Institute
City
Isfahan
Postal code
-
Phone
+98 31 3611 5210
Fax
-
Email
sadeghimasoumeh@gmail.com
Web page address
ICRI.mui.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Isfahan Cardiovascular Research Institute Isfahan University of Medical Sciences
Full name of responsible person
Masoumeh Sadeghi MD
Position
Professor of Cardiology
Other areas of specialty/work
Street address
Isfahan
City
Isfahan
Postal code
-
Phone
+98 31 3611 5210
Fax
-
Email
sadeghimasoumeh@gmail.com
Web page address
ICRI.mui.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Cardiovascular Research Institute
Full name of responsible person
Masoumeh Sadeghi MD
Position
Professor of Cardiology
Other areas of specialty/work
Street address
Moshtagh sevom Ave, Cardiovascular Research Institute
City
Isfahan
Postal code
-
Phone
+98 31 3611 5208
Fax
-
Email
sadeghimasoumeh@gmail.vom
Web page address
icri.mui.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)